Our Research Publications

Updated August 2025

Title Authors Year Journal Link to Article Intended Audience Purpose
Characterization of the growth dynamics and biofilm formation of Staphylococcus epidermidis strains isolated from contaminated platelet units Ali H, Greco-Stewart VS, Jacobs MR, Yomtovian RA, Rood IG, de Korte D, Ramirez-Arcos S 2014 J Med Microbiol View Blood operators Basic research
gT-S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo Sheffield WP, Lambourne MD, Eltringham-Smith LJ, Bhakta V, Arnold DM, Crowther MA 2014 J Thromb Haemost View Researchers Basic research
Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women Bigham M, Konrad S, Van Buynder P, Van Buynder J, Isaac-Renton J, ElSherif M, Halperin SA 2014 Vaccine View Health care providers Clinical research
Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions Hansen A, Yi QL, Acker JP 2013 Transfusion View Researchers New or improved product or process
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H 2013 Thromb Haemost View Researchers Basic research
The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors O'Brien SF, Goldman M, Scalia V, Yi QL, Fan W, Xi G, Dines IR, Fearon MA 2013 Transfus Med View Blood operators Clinical research
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ, PROTECT Investigators on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Clinical Trials Group 2013 Thromb Res View Researchers Clinical research
Challenges in the management of the blood supply Williamson LM, Devine DV 2013 Lancet View Blood operators Other
Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition Roddick LA, Bhakta V, Sheffield W 2013 BMC Biochem View Researchers Basic research
Legal Aspects of the Blood System in Canada Reis NM 2013 Public Health Law and Policy in Canada View Other Other
Positioning new treatments in the management of immune thrombocytopenia Arnold DM 2013 Pediatr Blood Cancer View Researchers Clinical research
Rapid removal of glycerol from frozen-thawed red blood cells Lusianti RE, Benson JD, Acker JP, Higgins AZ 2013 Biotechnol Prog View Researchers New or improved product or process
A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada Fearon MA, Scalia V, Huang M, Dines I, Ndao M 2013 Can J Infect Dis Med Microbiol View Health care providers Clinical research
Research with Blood Donated to Blood Banking Organizations Reis NM 2013 Health Law Review View Other Other
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators 2013 Transfusion View Researchers Clinical research
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway Crow AR, Yu H, Han D, Lazarus AH 2013 PLoS One View Researchers Basic research
Donor hemovigilance Goldman M 2013 Blood Transfus View Health care providers Other
Expert approaches to common bleeding and thrombotic problems, part II Hayward CP, Webert KE 2013 Semin Thromb Hemost View Health care providers Other
Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles Bicalho B, Holovati JL, Acker JP 2013 Biochim Biophys Acta View Researchers Basic research
The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP 2013 BMC Biochem View Researchers Basic research
Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion Tchir JD, Acker JP, Holovati JL 2013 Transfusion View Researchers Basic research
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D 2013 Intensive Care Med View Health care providers Clinical research
A platelet cover-up Arnold DM 2013 Blood View Researchers Other
Legal Foundations of Public Health Law Reis NM 2013 Public Health Law and Policy in Canada View Other Other
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV 2013 Transfusion View Researchers Basic research
Standardization of CD62P measurement: results of an international comparative study Levin E, Serrano K, Devine DV, for the Biomedical Excellence for Safer Transfusion Collaborative 2013 Vox Sang View Blood operators Benchmarking and standard setting
The use of the electronic (computer) cross-match Reesink HW, Davis K, Wong J, Schwartz DW, Mayr WR, Devine DV, Georgsen J, Chiaroni J, Ferrera V, Roubinet F, Lin CK, O'Donovan B, Fitzgerald JM, Raspollini E, Villa S, Rebulla P, Makino S, Gounder D, Safwenberg J, Murphy MF, Staves J, Milkins C, Mercado TC, Illoh OC, Panzer S 2013 Vox Sang View Blood operators Benchmarking and standard setting
Alloimmunization of patients by blood units harboring distinct DEL variants St-Louis M, Lebrun A, Goldman M, Lavoie M 2013 Immunohematology View Health care providers Clinical research
Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H 2013 Cardiovasc Hematol Disord Drug Targets View Researchers Other
Identifying D-positive donors using a second automated testing platform Goldman M, Resz I, Cote J, Ochoa G, Angus N 2013 Immunohematology View Blood operators New or improved product or process
ResearchUnit: Should patients receive HLA-selected platelets? Shehata N 2013 Blood.ca website View Other Other
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P 2013 Transfusion View Health care providers Benchmarking and standard setting
Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma Talbot K, Meixner SC, Pryzdial EL 2013 Biochim Biophys Acta View Researchers Basic research
ResearchUnit: How does consolidation of blood production and distribution services impact hospitals? Blake J 2013 Blood.ca website View Other Other
CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide Kim M, Binnington B, Sakac D, Lingwood CA, Branch DR 2013 AIDS View Researchers Basic research
Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues Trant JF, Briggs RA, Capicciotti C, Ben RN 2013 RSC Adv View Researchers Basic research
Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain Kurbegovic A, Trudel M 2013 Hum Mol Genet View Researchers Basic research
ResearchUnit: Doubling the 30-minute rule without compromising Red Blood Cells quality and safety. Ramirez-Arcos S 2013 Blood.ca website View Other Other
Thrombocytopenia in the critically ill Shehata N, Fontes ML 2013 Can J Anaesth View Researchers Other
Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update Sheffield WP, Bhakta V, Talbot K, Pryzdial ELG, Jenkins C 2013 Transfus Apher Sci View Blood operators Benchmarking and standard setting
ResearchUnit: Platelets are Immune Cells! Semple J 2013 Blood.ca website View Other Other
Synthesis of peptides and glycopeptides with polyproline II helical topology as potential antifreeze molecules Corcilius L, Santhakumar G, Stone RS, Capicciotti CJ, Joseph S, Matthews JM, Ben RN, Payne RJ 2013 Bioorg Med Chem View Researchers Basic research
Transfusion medicine data as product Skeate RC 2013 Transfusion View Researchers Other
N-ethylmaleimide activates a Cl(-)-independent component of K(+) flux in mouse erythrocytes Shmukler BE, Hsu A, Alves J, Trudel M, Rust MB, Hubner CA, Rivera A, Alper SL 2013 Blood Cells Mol Dis View Researchers Basic research
Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation Wiebe C, Nickerson P 2013 Curr Opin Organ Transplant View Health care providers Clinical research
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists Ghadaki B, Nazi I, Kelton JG, Arnold DM 2013 Transfusion View Health care providers Clinical research
Unraveling the IVIG mystique Branch DR 2013 Transfusion View Researchers Other
What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers Lane S, Arnold E, Webert KE, Chan A, Walker I, Heddle NM 2013 Haemophilia View Health care providers Other
Allowing blood donation from men who had sex with men more than 5 years ago: a model to evaluate the impact on transfusion safety in Canada Germain M, Robillard P, Delage G, Goldman M 2013 Vox Sang View Blood operators New or improved product or process
Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo Imran ul-haq M, Hamilton JL, Lai BF, Shenoi RA, Horte S, Constantinescu I, Leitch HA, Kizhakkedathu JN 2013 ACS Nano View Researchers Basic research